Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-090703
Filing Date
2024-08-05
Accepted
2024-08-05 16:01:10
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8733
  Complete submission text file 0000950170-24-090703.txt   12202
Mailing Address C/O ACCESS INDUSTRIES 730 FIFTH AVENUE NEW YORK NY 10019
Business Address
Blavatnik Len (Reporting) CIK: 0001326628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 241174621

Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Reporting) CIK: 0001391297 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 241174623

Mailing Address 730 FIFTH AVENUE NEW YORK NY 10019
Business Address 730 FIFTH AVENUE NEW YORK NY 10019 2122476400
ACCESS INDUSTRIES MANAGEMENT, LLC (Reporting) CIK: 0001508226 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 241174622

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019 212-247-6400
AI Day1 LLC (Reporting) CIK: 0001863302 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 241174624